跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUCRIN DEPOT leuprorelin acetate 3.75mg powder for injection prefilled dual-chamber syringe - TGA Drug Approval Details
Approvals
/
TGA
/
LUCRIN DEPOT leuprorelin acetate 3.75mg powder for injection prefilled dual-chamber syringe
Approved
STANDARD
LUCRIN DEPOT leuprorelin acetate 3.75mg powder for injection prefilled dual-chamber syringe
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
10fea74da219051d
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
10fea74da219051d
Product Name
LUCRIN DEPOT leuprorelin acetate 3.75mg powder for injection prefilled dual-chamber syringe
Artg Id
337373
Artg Name
LUCRIN DEPOT leuprorelin acetate 3.75mg powder for injection prefilled dual-chamber syringe
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2020-06-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
10fea74da219051d
Type
Standard
Back to TGA Approvals
